-         The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of small molecule GLP-1 receptor (GLP-1R) agonist ASC30 in 65 participants with obesity or overweight.
-Â Â Â Â Â Â Â Â Â The ultra-long-acting SQÂ depot treatment formulation of small molecule ASC30 demonstrated a 46-day observed half-life in participants with obesity in the Phase Ib study, supporting once-monthly administration.
kAm\Â Â Â Â Â Â Â Â Â k6>m%@A=:?6 52E2 7C@> E96 `a\H66< !92D6 xx2 DEF5J @7 p$rb_ @?46\>@?E9=J $" 56A@E EC62E>6?E 7@C>F=2E:@? 2C6 6IA64E65 :? E96 7:CDE BF2CE6C @7 a_ae]k^6>mk^Am
kAm\         k6>m%96k^6>m k6>mr@>A2?Jk^6>m k6>mH:==k^6>m k6>m9@DEk^6>m k6>m2k^6>mk6>m 4@?76C6?46 42==k^6>m k6>m:? |2?52C:? E@52Jk^6>m k6>m2Ek^6>m k6>m`_i__ 2]>] r9:?2 $E2?52C5 %:>6]k^6>m k^Am
kAmkDA2? 4=2DDlQ=686?5$A2?r=2DDQmw~}v z~}vk^DA2?m[ kDA2? 4=2DDlQ=686?5$A2?r=2DDQm~4E] `h[ a_adk^DA2?m ^!#}6HDH:C6^ \\ pD4=6E:D !92C>2 x?4] Wwzt)i `efa[ QpD4=6E:DQX 2??@F?46D E96 C646?E 4@>A=6E:@? @7 6?C@==>6?E :? E96 &]$] !92D6 xx2 DEF5J 7@C :ED @?46\>@?E9=J DF34FE2?6@FD W$"X 56A@E 7@C>F=2E:@? WEC62E>6?E 7@C>F=2E:@?X @7 D>2== >@=64F=6 kDA2?mv{!\`k^DA2?m C646AE@C Wv{!\`#X 28@?:DE p$rb_ 7@C E96 EC62E>6?E @7 @36D:EJ Wk2 9C67lQ9EEADi^^4=:?:42=EC:2=D]8@G^DEF5J^}r%_eefhhdhn4@?5lp$rb_U2>AjC2?<lbQ E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm}r%_eefhhdhk^2mX] p== ed A2CE:4:A2?ED 2C6 @36D6 @C @G6CH6:89E H:E9 2E =62DE @?6 H6:89E\C6=2E65 4@>@C3:5:EJ]k^Am
kAm%96 !92D6 xx2 DEF5J @7 p$rb_ @?46\>@?E9=J $" 56A@E EC62E>6?E 7@C>F=2E:@? :D 2 `a\H66<[ C2?5@>:K65[ 5@F3=6\3=:?5[ A=2463@\4@?EC@==65 2?5 >F=E:\46?E6C DEF5J 4@?5F4E65 :? E96 &]$] E@ 6G2=F2E6 E96 D276EJ[ E@=6C23:=:EJ 2?5 677:424J :? A2CE:4:A2?ED H:E9 @36D:EJ W3@5J >2DD :?56I Wq|xX ≥ b_ <8^>kDFAmak^DFAmX @C @G6CH6:89E Wq|x ≥ af <8^>kDFAmak^DFAm 3FE U=Ej b_ <8^>kDFAmak^DFAmX H:E9 2E =62DE @?6 H6:89E\C6=2E65 4@>@C3:5:EJ] %96 DEF5J 4@?D:DED @7 E9C66 4@9@CED @7 5:776C6?E 5@D6D[ H:E9 2 E@E2= @7 ed A2CE:4:A2?ED] %@A=:?6 52E2 2C6 6IA64E65 :? E96 7:CDE BF2CE6C @7 a_ae]k^Am
kAm%96 F=EC2\=@?8\24E:?8 $" 56A@E EC62E>6?E 7@C>F=2E:@? @7 D>2== >@=64F=6 p$rb_ 56>@?DEC2E65 2 ce\52J @3D6CG65 92=7\=:76 W2D >62DFC65 3J E:>6 E@ d_T rkDF3m>2Ik^DF3mX :? A2CE:4:A2?ED H:E9 @36D:EJ :? E96 !92D6 x3 DEF5JÂ Wk2 9C67lQ9EEADi^^4=:?:42=EC:2=D]8@G^DEF5J^}r%_eefhhdhn4@?5lp$rb_U2>AjC2?<lbQ E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm}r%_eefhhdhk^2mX[ DFAA@CE:?8 @?46\>@?E9=J 25>:?:DEC2E:@?]Â p$rb_ EC62E>6?E 7@C>F=2E:@?VD E6C>:?2= 92=7\=:76 H2D be 52JD]k^Am
kAmuFCE96C>@C6[ E96 &]$] !92D6 x3 D:?8=6 2D46?5:?8 5@D6 W$psX DEF5J 56>@?DEC2E65 E92E 4@>A2C65 E@ E96 EC@F89 4@?46?EC2E:@? @7 p$rb_ 2E s2J ah[ E96 F=EC2\=@?8\24E:?8 $" 56A@E EC62E>6?E 7@C>F=2E:@? D9@H65 2 A62<\E@\EC@F89 C2E:@ @7 2AAC@I:>2E6=J `]d E@Â `]Â %96 AC@AC:6E2CJ $" 56A@E D=@H\C6=62D6 EC62E>6?E 7@C>F=2E:@? @7 p$rb_ H2D 56G6=@A65 7C@>Â pD4=6E:DV &=EC2\{@?8\p4E:?8 !=2E7@C>Â W&{p!X] pD4=6E:DV &{p! E649?@=@8J 5@6D ?@E 92G6 E96 =:>:E2E:@?D @7 2=3F>:?\56A6?56?E 92=7\=:76 6IE6?D:@? E649?@=@8J[ 4FCC6?E=J 36:?8 2AA=:65 E@ >2?J A6AE:56 5CF8D 2?5 42?5:52E6D[ H9:49 =:>:ED 92=7\=:76 6IE6?D:@? E@ E96 92=7\=:76 @7 2=3F>:? W2AAC@I:>2E6=J a_ 52JDX]k^Am
kAmQr@>A=6E:?8 6?C@==>6?E :? E9:D DEF5J :D 2? :>A@CE2?E >:=6DE@?6[ >2C<:?8 D:8?:7:42?E AC@8C6DD :? @FC 56G6=@A>6?E @7 E9:D :??@G2E:G6 E96C2AJ[Q D2:5 y:?K: y2D@? (F[ !9]s][ u@F?56C[ r92:C>2? 2?5 rt~ @7 pD4=6E:D[ QpD4=6E:DV AC@AC:6E2CJ F=EC2\=@?8\24E:?8 $" 56A@E EC62E>6?E 7@C>F=2E:@? @7 p$rb_[ H:E9 :ED ce\52J @3D6CG65 92=7\=:76 2?5 72G@C23=6 A62<\E@\EC@F89 C2E:@ @7 2AAC@I:>2E6=J `]d E@ `[ 56>@?DEC2E65 E96 A@E6?E:2= E@ 364@>6 2 @?46\>@?E9=J EC62E>6?E @AE:@? 7@C @36D:EJ] (6 2C6 =@@<:?8 7@CH2C5 E@ E@A=:?6 52E2 7C@> E9:D !92D6 xx2 DEF5J :? E96 7:CDE BF2CE6C @7 a_ae]Qk^Am
kAmp$rb_ H2D 5:D4@G6C65 2?5 56G6=@A65 :?\9@FD6 2E pD4=6E:D 2D 2 7:CDE 2?5 @?=J :?G6DE:82E:@?2= D>2== >@=64F=6 v{!\`# 3:2D65 28@?:DE 56D:8?65 E@ 36 25>:?:DE6C65 @?46 52:=J @C2==J 2?5 @?46 >@?E9=J E@ @?46 BF2CE6C=J DF34FE2?6@FD=J 2D 2 EC62E>6?E E96C2AJÂ 2?5 2 >2:?E6?2?46 E96C2AJ 7@C 49C@?:4 H6:89E >2?286>6?E]k^Am
kAmkDEC@?8mr@?76C6?46 r2==k^DEC@?8mk^Am
kAmpD4=6E:D H:== 9@DE 2 4@?76C6?46 42== :? |2?52C:? E@52J[ ~4E@36C a_[ a_ad 2E `_i__ 2]>] r9:?2 $E2?52C5 %:>6] p =:G6 H6342DE @7 E96 42== H:== 36 2G2:=23=6 G:2 %646?E |66E:?8^ '@@' |66E:?8[ H:E9 E96 |66E:?8 xsi a`e\aga\bbh[ @C 2446DD =:?<D @7ik^Am
kAmr9:?6D6 |2:?=2?5 kDFAm,`.k^DFAmi k2 9C67lQ9EEADi^^>66E:?8]E6?46?E]4@>^5>^g{3!%huDhw@(Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9EEADi^^>66E:?8]E6?46?E]4@>^5>^g{3!%huDhw@(k^2mj @Ck^Am
kAmx?E6C?2E:@?2=i k2 9C67lQ9EEADi^^G@@G>66E:?8]4@>^5>^g{3!%huDhw@(Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9EEADi^^G@@G>66E:?8]4@>^5>^g{3!%huDhw@(k^2m]k^Am
k5:GmkE23=6 3@C56ClQ_Q 46==DA24:?8lQ_Q 46==A255:?8lQ`Q 4=2DDlQAC?344QmkECmkE5 4=2DDlQAC?ACa AC?A=a AC?D3E3` AC?C3C3` AC?D333` AC?D3=3`Q 4@=DA2?lQ`Q C@HDA2?lQ`QmkA 4=2DDlQAC?>=cQmkDA2? 4=2DDlQAC?6HD0DA2?Qm,`. r9:?6D6 |2:?=2?5i E96 !6@A=6VD #6AF3=:4 @7 r9:?2[ 6I4=F5:?8[ 7@C E96 AFCA@D6 @7 E9:D AC6DD C6=62D6[ w@?8 z@?8[ |242F $A64:2= p5>:?:DEC2E:G6 #68:@? 2?5 %2:H2?[ r9:?2] k^DA2?mk^Amk^E5mk^ECmk^E23=6mk^5:Gm
kAmkDEC@?8mp3@FE p$rb_k^DEC@?8mk^Am
kAmp$rb_ :D 2? :?G6DE:82E:@?2= v{!\`# 3:2D65 D>2== >@=64F=6 28@?:DE 2?5 92D F?:BF6 2?5 5:776C6?E:2E65 AC@A6CE:6D E92E 6?23=6 E96 D2>6 D>2== >@=64F=6 7@C 3@E9 @C2= E23=6E 2?5 DF34FE2?6@FD :?;64E:@? 25>:?:DEC2E:@?D] p$rb_ :D 2 ?6H 496>:42= 6?E:EJ W}rtX[ H:E9 &]$] 2?5 8=@32= 4@>A@F?5 A2E6?E AC@E64E:@? F?E:= a_cc H:E9@FE A2E6?E 6IE6?D:@?D] k^Am
kAmkDEC@?8mp3@FE pD4=6E:D !92C>2 x?4]k^DEC@?8mk^Am
kAmpD4=6E:D !92C>2 x?4] :D 2 7F==J :?E68C2E65 3:@E649?@=@8J 4@>A2?J 7@4FD65 @? E96 56G6=@A>6?E 2?5 4@>>6C4:2=:K2E:@? @7 A@E6?E:2= 36DE\:?\4=2DD 2?5 7:CDE\:?\4=2DD E96C2A6FE:4D E@ EC62E >6E23@=:4 5:D62D6D] &E:=:K:?8 :ED AC@AC:6E2CJ pCE:7:4:2= x?E6==:86?46\pDD:DE65 $ECF4EFC6\q2D65 sCF8 s:D4@G6CJ Wpx$qssX 2?5 &=EC2\{@?8\p4E:?8 !=2E7@C> W&{p!X E649?@=@8:6D[ pD4=6E:D 92D 56G6=@A65 >F=E:A=6 5CF8 42?5:52E6D :?\9@FD6[ :?4=F5:?8 :ED =625 AC@8C2>[ p$rb_[ 2 D>2== >@=64F=6 v{!\`# 28@?:DE 56D:8?65 E@ 36 25>:?:DE6C65 @?46 52:=J @C2==J 2?5 @?46 >@?E9=J E@ @?46 BF2CE6C=J DF34FE2?6@FD=J 2D 2 EC62E>6?E E96C2AJ 2?5 2 >2:?E6?2?46 E96C2AJ 7@C 49C@?:4 H6:89E >2?286>6?E] pD4=6E:D :D =:DE65 @? E96 w@?8 z@?8 $E@4< tI492?86 W`efa]wzX]k^Am
kAmu@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:E k2 9C67lQ9EEAi^^HHH]2D4=6E:D]4@>^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHHH]2D4=6E:D]4@>k^2m]k^Am
kAmr@?E24E：k^Am
kAm!6E6C '@KK@k^Am
kAmxr# w62=E942C6k^Am
kAmccb\ab`\_d_d W&]$]Xk^Am
kAmk2 9C67lQ>2:=E@i!6E6C]G@KK@o:4C962=E942C6]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm!6E6C]G@KK@o:4C962=E942C6]4@>k^2mk^Am
kAmpD4=6E:D !92C>2 x?4] !# 2?5 x# E62>Dk^Am
kAmZge\`g`\_ed_\h`ah Wr9:?2Xk^Am
kAmk2 9C67lQ>2:=E@iACo2D4=6E:D]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmACo2D4=6E:D]4@>k^2mk^Am
kAmk2 9C67lQ>2:=E@i:Co2D4=6E:D]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm:Co2D4=6E:D]4@>k^2mk^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}__edcU2>AjD5la_ad\`_\`hQ ^m ':6H @C:8:?2= 4@?E6?Eik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2D4=6E:D\4@>A=6E6D\6?C@==>6?E\:?\FD\A92D6\::2\DEF5J\7@C\:ED\@?46\>@?E9=J\DF34FE2?6@FD\56A@E\EC62E>6?E\7@C>F=2E:@?\@7\D>2==\>@=64F=6\8=A\`C\28@?:DE\2D4b_\7@C\@36D:EJ\b_adgfcgd]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2D4=6E:D\4@>A=6E6D\6?C@==>6?E\:?\FD\A92D6\::2\DEF5J\7@C\:ED\@?46\>@?E9=J\DF34FE2?6@FD\56A@E\EC62E>6?E\7@C>F=2E:@?\@7\D>2==\>@=64F=6\8=A\`C\28@?:DE\2D4b_\7@C\@36D:EJ\b_adgfcgd]9E>=k^2mk^Am
kAm$~&#rt pD4=6E:D !92C>2 x?4]k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}__edcU2>Aj%C2?D>:DD:@?0x5la_ad`_`ha_`_!#0}t($0&$!#00000r}__edcU2>Ajs2E6x5la_ad`_`hQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.